Literature DB >> 10701366

ras-p21-induced cell transformation: unique signal transduction pathways and implications for the design of new chemotherapeutic agents.

M R Pincus1, P W Brandt-Rauf, J Michl, R P Carty, F K Friedman.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10701366     DOI： 10.3109/07357900009023061

Source DB:  PubMed          Journal:  Cancer Invest        ISSN： 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  4 in total

1.  Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells.

Authors:  M Kanovsky; A Raffo; L Drew; R Rosal; T Do; F K Friedman; P Rubinstein; J Visser; R Robinson; P W Brandt-Rauf; J Michl; R L Fine; M R Pincus
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

2.  Comparison of the predicted structures of loops in the ras-SOS protein bound to a single ras-p21 protein with the crystallographically determined structures in SOS bound to two ras-p21 proteins.

Authors:  Steven Smith; Mark Hyde; Matthew R Pincus
Journal:  Protein J       Date:  2005-08       Impact factor: 2.371

3.  L-NAME has opposite effects on the productions of S-adenosylhomocysteine and S-adenosylmethionine in V12-H-Ras and M-CR3B-Ras pheochromocytoma cells.

Authors:  Maia Sephashvili; Elene Zhuravliova; Tamar Barbakadze; Mukhran Khundadze; Nana Narmania; David G Mikeladze
Journal:  Neurochem Res       Date:  2006-09-27       Impact factor: 3.996

4.  Novel peptides from the RAS-p21 and p53 proteins for the treatment of cancer.

Authors:  Wilbur B Bowne; Josef Michl; Martin H Bluth; Michael E Zenilman; Matthew R Pincus
Journal:  Cancer Ther       Date:  2007
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.